<DOC>
	<DOCNO>NCT00899847</DOCNO>
	<brief_summary>To evaluate toxicity tolerability tandem autologous/allogeneic transplant approach patient advanced stage multiple myeloma .</brief_summary>
	<brief_title>Ph II Autologous Followed Nonmyeloablative Allogeneic Transplantation Using TLI &amp; ATG</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Mechlorethamine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>3.1.1 Stage IIIII multiple myeloma progression initial treatment Stage I disease ( Durie Salmon Staging ) . Patients plasma cell leukemia also include . 3.1.2 Pathology review diagnosis confirm Stanford University Medical Center . 3.1.3 Age &gt; 18 year &lt; = 75 year . 3.1.4 Karnofsky Performance Status &gt; 70 % . 3.1.5 Corrected DLCO &gt; 60 % 3.1.6 Left ventricle ejection fraction ( LVEF ) &gt; 50 % . 3.1.7 ALT AST must &lt; = 2X normal . Total bilirubin &lt; = 2 mg/dL unless hemolysis Gilbert 's disease . 3.1.8 Estimated creatinine clearance &gt; 50 ml/min . 3.1.9 Have relate unrelated HLAidentical donor one antigen/allele mismatch HLAA , B , C DRB1 . 3.1.10 Signed inform consent . 3.3 Donor Evaluation Inclusion Criteria 3.3.1 Age &gt; =17 . 3.3.2 HIV seronegative 3.3.3 Donor must capable give sign , inform consent 3.3.4 No contraindication administration GCSF 3.3.5 Willing central venous catheter place apheresis peripheral vein inadequate . 3.2.1 Prior allogeneic hematopoietic cell transplantation . 3.2.2 Uncontrolled active infection . 3.2.4 Uncontrolled congestive heart failure angina . 3.2.5 Pregnancy nursing patient exclude study . 3.2.6 Those HIVpositive exclude study due high risk lethal infection hematopoietic cell transplantation . 3.4 Donor Evaluation Exclusion Criteria 3.4.1 Serious medical psychological illness . 3.4.2 Pregnant lactate woman eligible 3.4.3 Prior malignancy within last 5 year except nonmelanoma skin cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>